Injectable ECM scaffolds for cardiac repair.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cardiovascular Research

Background:

• Injectable biomaterials are explored for minimally invasive treatment of myocardial infarction (MI) and heart failure.
• Early studies demonstrated improved cardiac function post-MI with biomaterial injections.
• Decellularized extracellular matrix (ECM) hydrogels show significant promise for cardiac repair.

Purpose of the Study:

• To present methods for fabricating an injectable cardiac-specific ECM biomaterial.
• To detail the injection procedure into rat myocardium via a diaphragmatic surgical approach.
• To highlight the potential for incorporating cells or therapeutics for regenerative strategies.

Main Methods:

• Fabrication of an injectable, cardiac-specific decellularized extracellular matrix (ECM) biomaterial.
• Surgical injection of the biomaterial into rat myocardium using a transdiaphragmatic approach.
• Review of prior studies demonstrating positive outcomes in animal models.

Main Results:

• The described ECM biomaterial has shown positive outcomes in small and large animal models for cardiac repair.
• The methods facilitate the delivery of biomaterials for potential therapeutic applications.
• The injectable nature allows for minimally invasive delivery.

Conclusions:

• Injectable cardiac ECM biomaterials represent a promising therapeutic approach for myocardial repair.
• The presented methods enable the fabrication and delivery of these biomaterials.
• This approach holds potential for future regenerative medicine strategies in cardiology.